Assays and methods for selecting a treatment regimen for a subject with leukemia
US11746386B2 · kind B2 · utility
1Cited by
7References
8Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Feb 11, 2021 |
| Grant date | Sep 5, 2023 |
| Priority date | — |
| Expiry date | Feb 26, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Diagnostic methods for identifying cancer bearing subjects appropriate for treatment with CPX-351 include genetic and ex vivo testing of cells from a candidate subject. Combination treatment with CPX-351 and FLT-3 inhibitors improve CPX-351 uptake and toxicity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.